Stock CLXT CIBUS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cibus, Inc. Nasdaq

Equities

CLXT

US17166A1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-28 pm EDT 		5-day change 1st Jan Change
9.85 USD +3.79% Intraday chart for Cibus, Inc. -1.50% -49.85%
Jun. 26 Cibus, Inc. Expands Its Intellectual Property Coverage for Plant Gene Editing and Traits CI
May. 30 Cibus? White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CIBUS, INC. Stock Cibus, Inc.
-49.85% 226M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+4.18% 211B
B
DANAHER CORPORATION Stock Danaher Corporation
+8.00% 185B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+31.86% 158B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+33.21% 113B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.28% 64.32B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+21.14% 55.66B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+0.11% 48.41B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-6.76% 37.82B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.78% 35.57B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. CLXT Stock
  4. CLXT Stock
  5. Ratings Cibus, Inc.